Xcell Therapeutics Inc.

Xcell Therapeutics Inc. develops and produces drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium used to develop human mesenchymal stem cells, and XPorT, a platform that aims to develop optimal media from the user's perspective using a variety of cells. The company also develops media for cell culture in areas such as cell therapy, gene therapy, exosomes, organoids, and bioreactors. Founded in 2015, it is based in Seoul, South Korea.